StayHappi Glimepiride+Metformin+Voglibose 2mg/500mg/0.3mg Tablet

By StayHappi

Rx

10 Tablet in a Strip

Composition icon

Composition

Glimepiride(2mg) + Metformin(500mg) + Voglibose(0.3mg)

Manufacturer - Sarvagunaushdhi Pvt Ltd icon

Manufacturer - Sarvagunaushdhi Pvt Ltd

13Th Floor, Pearl Best Hight-1, Netaji Subhash Place, Pitampura, Delhi North Delhi DL 110034 IN

Expires on or after icon

Expires on or after

September, 2025

About StayHappi Glimepiride+Metformin+Voglibose 2mg/500mg/0.3mg Tablet

StayHappi Glimepiride+Metformin+Voglibose 2mg/500mg/0.3mg Tablet is classified as an anti-diabetic medication designed to manage type 2 diabetes mellitus in adult patients. This medication is formulated as a combination of three potent drugs that work together to regulate blood sugar levels in individuals with diabetes. It is crucial to consume StayHappi Glimepiride+Metformin+Voglibose 2mg/500mg/0.3mg Tablet alongside a meal to optimize its effectiveness.

The dosage of StayHappi Glimepiride+Metformin+Voglibose 2mg/500mg/0.3mg Tablet should be administered consistently at the same time daily as recommended by your healthcare provider. The prescribed dosage may be adjusted periodically based on your blood sugar levels and how well the medication is controlling them. It is essential to adhere to the treatment plan and continue taking the medication, even if you feel well or your blood sugar seems to be under control.

It is vital to understand that discontinuing StayHappi Glimepiride+Metformin+Voglibose 2mg/500mg/0.3mg Tablet without medical consultation can lead to elevated blood sugar levels, posing risks such as kidney damage, vision impairment, nerve complications, and limb amputation. This medication complements a comprehensive treatment program that includes a balanced diet, regular physical activity, and weight management strategies recommended by your healthcare provider to effectively manage diabetes.

One of the primary side effects associated with StayHappi Glimepiride+Metformin+Voglibose 2mg/500mg/0.3mg Tablet is hypoglycemia, characterized by low blood glucose levels. Recognizing symptoms such as perspiration, lightheadedness, headaches, and tremors is crucial. Always carry a quick-acting glucose source like sugary foods or fruit juice to combat hypoglycemia. Consumption of alcohol can heighten the risk of low blood sugar and should be avoided while taking this medication.

Apart from hypoglycemia, additional side effects that may occur with the use of StayHappi Glimepiride+Metformin+Voglibose 2mg/500mg/0.3mg Tablet include alterations in taste perception, nausea, diarrhea, abdominal discomfort, headaches, swelling, visual disturbances, bone fractures, and upper respiratory tract infections. Some individuals may experience weight gain while on this medication.

Individuals with type 1 diabetes, diabetic ketoacidosis, severe kidney or liver conditions, or a history of heart disease should refrain from taking StayHappi Glimepiride+Metformin+Voglibose 2mg/500mg/0.3mg Tablet. Pregnant or nursing women should seek medical guidance before initiating this treatment. Regular monitoring of blood sugar levels and periodic blood tests to assess blood parameters and liver function are essential components of managing diabetes with this medication.


Benefits

StayHappi Glimepiride+Metformin+Voglibose 2mg/500mg/0.3mg Tablet offers several benefits for individuals with Type 2 diabetes mellitus. This medication plays a crucial role in controlling high blood glucose levels, which is essential in diabetes management. By slowing down the breakdown of food into simple glucose in the intestine, it helps prevent rapid spikes in blood sugar after meals. Additionally, StayHappi Glimepiride+Metformin+Voglibose 2mg/500mg/0.3mg Tablet aids in eliminating excess glucose through urine, thereby assisting in lowering overall blood glucose levels.


Maintaining optimal blood glucose levels is vital in reducing the risk of serious diabetes complications such as kidney damage, eye problems, nerve issues, and even limb amputation. Moreover, individuals with Type 2 diabetes who also have cardiovascular disease can benefit from StayHappi Glimepiride+Metformin+Voglibose 2mg/500mg/0.3mg Tablet, as it helps lower the risk of mortality from cardiovascular conditions. Consistent use of this medication, in conjunction with a balanced diet and regular exercise, can contribute significantly to leading a normal and healthy life.


It is recommended to adhere to the prescribed regimen of StayHappi Glimepiride+Metformin+Voglibose 2mg/500mg/0.3mg Tablet as it plays a protective role in safeguarding future health outcomes. By following the treatment plan diligently, individuals can effectively manage their diabetes, reduce risks associated with complications, and enhance their overall well-being.


How to use the StayHappi Glimepiride+Metformin+Voglibose 2mg/500mg/0.3mg Tablet

To use StayHappi Glimepiride+Metformin+Voglibose 2mg/500mg/0.3mg Tablet, follow your doctor's instructions on the dose and duration. This medication should be swallowed whole without chewing, crushing, or breaking it. Remember to take StayHappi Glimepiride+Metformin+Voglibose 2mg/500mg/0.3mg Tablet on an empty stomach. Make sure to adhere to the recommended dose and duration as prescribed by your doctor for best results. If you have any questions or concerns about how to use this medication, consult your healthcare provider for further guidance.


Uses of StayHappi Glimepiride+Metformin+Voglibose 2mg/500mg/0.3mg Tablet

The StayHappi Glimepiride+Metformin+Voglibose 2mg/500mg/0.3mg Tablet is primarily used for the treatment of Type 2 diabetes mellitus, a common condition in which the body is unable to properly regulate blood sugar levels. By taking this tablet as prescribed by a healthcare provider, individuals with Type 2 diabetes mellitus can help manage their condition and improve their overall health. This medication combines specific doses of active ingredients to target the underlying causes of diabetes and control blood glucose levels effectively. When used correctly, StayHappi Glimepiride+Metformin+Voglibose 2mg/500mg/0.3mg Tablet can be a valuable tool in the management of Type 2 diabetes mellitus.


What conditions StayHappi Glimepiride+Metformin+Voglibose 2mg/500mg/0.3mg Tablet treats?

StayHappi Glimepiride+Metformin+Voglibose 2mg/500mg/0.3mg Tablet is used to treat type 2 diabetes mellitus in adults by controlling blood sugar levels. It is important to take it consistently with food at the same time each day. Even if you feel well, continue this medication as stopping abruptly could lead to serious complications like kidney damage or nerve problems. Alongside medication, maintaining a healthy lifestyle involving diet, exercise, and weight management is crucial in managing diabetes. Regular monitoring, awareness of low blood sugar symptoms, and avoiding alcohol are essential. Avoid if you have certain conditions like type 1 diabetes or severe kidney disease. Consult your doctor if side effects persist.


Should you consult a doctor?

Seek medical attention if you experience persistent side effects such as nausea, diarrhea, abdominal pain, hypoglycemia (low blood glucose level), or loss of appetite. Additionally, consult your doctor if you have symptoms of low blood glucose levels like sweating, dizziness, headache, and shaking. It is crucial to seek medical help if you have any concerns or if side effects persist, especially if you have pre-existing health conditions such as heart disease, severe kidney or liver disease, or if you are pregnant or breastfeeding. Regular monitoring of blood sugar levels is essential, and any unusual symptoms should be reported to your healthcare provider promptly for proper evaluation and management. Remember, your doctor is there to support you in managing your diabetes and ensuring your well-being.


Side effects of StayHappi Glimepiride+Metformin+Voglibose 2mg/500mg/0.3mg Tablet

When taking StayHappi Glimepiride+Metformin+Voglibose 2mg/500mg/0.3mg Tablet, you may experience certain side effects. Many of these side effects do not typically need medical attention and tend to improve as your body gets used to the medication. However, if these side effects persist or if you have concerns about them, it's important to consult your doctor. Common side effects of StayHappi Glimepiride+Metformin+Voglibose 2mg/500mg/0.3mg Tablet may include nausea, diarrhea, abdominal pain, hypoglycemia (having low blood glucose levels), and loss of appetite.


Safety advice

scroll

liver

When using StayHappi Glimepiride+Metformin+Voglibose 2mg/500mg/0.3mg Tablet, it is important to be cautious if you have liver disease. In such cases, your doctor may need to adjust the dosage of the medication. Patients with mild to moderate liver disease usually start with a lower dose of StayHappi Glimepiride+Metformin+Voglibose 2mg/500mg/0.3mg Tablet. However, it is not advisable to use this medication if you have severe liver disease. Make sure to consult your doctor for proper guidance when considering the use of StayHappi Glimepiride+Metformin+Voglibose 2mg/500mg/0.3mg Tablet.

scroll

kidney

StayHappi Glimepiride+Metformin+Voglibose 2mg/500mg/0.3mg Tablet may not be safe for people with kidney disease. It is advised to avoid using this medication in such cases. Consulting a doctor is recommended before use.

scroll

alcohol

It is not safe to drink alcohol while taking StayHappi Glimepiride+Metformin+Voglibose 2mg/500mg/0.3mg Tablet.

scroll

driving

Caution is advised when driving if experiencing low or high blood sugar symptoms with StayHappi Glimepiride+Metformin+Voglibose 2mg/500mg/0.3mg Tablet. Refrain from driving in such cases.

scroll

pregnancy

StayHappi Glimepiride+Metformin+Voglibose 2mg/500mg/0.3mg Tablet may not be safe for use during pregnancy, as animal studies have shown harmful effects on the developing baby. Your doctor will assess the benefits and risks before prescribing it to you. Please consult your doctor.

scroll

breastfeeding

StayHappi Glimepiride+Metformin+Voglibose 2mg/500mg/0.3mg Tablet is likely unsafe during breastfeeding, as evidence indicates it may pass into breastmilk and harm the baby.


Consumption warning before consuming StayHappi Glimepiride+Metformin+Voglibose 2mg/500mg/0.3mg Tablet

Before taking StayHappi Glimepiride+Metformin+Voglibose 2mg/500mg/0.3mg Tablet, it is important to note a few things. This medicine helps in treating type 2 diabetes and should be taken with food at the same time daily. Even if you feel well, continue taking it as stopping abruptly can lead to high blood sugar levels, risking kidney damage, blindness, nerve problems, or loss of limbs. Remember, it is just one part of the treatment plan, which should include a healthy diet, exercise, and weight management as per your doctor's advice. Common side effects may include low blood sugar levels, so be aware of symptoms like sweating, dizziness, and shaking. Carry a quick sugar source always. Avoid alcohol as it can lower your blood sugar. Other side effects may include taste changes, nausea, and weight gain. Do not use if you have type 1 diabetes, diabetic ketoacidosis, severe kidney or liver disease, or heart problems. Pregnant or nursing women should consult their doctor before taking this medication. Regular blood tests are advised to monitor your health while on this medication.


What if you forgot to take StayHappi Glimepiride+Metformin+Voglibose 2mg/500mg/0.3mg Tablet?

If you forget to take a dose of StayHappi Glimepiride+Metformin+Voglibose 2mg/500mg/0.3mg Tablet, try to take it as soon as you remember. But if it's nearly time for your next scheduled dose, just skip the missed one and continue with your regular dosing routine. Avoid taking a double dose to make up for the missed one. Remember, it's important to stick to the prescribed dosing schedule for the best results.


Related lab tests

For monitoring the effects of StayHappi Glimepiride+Metformin+Voglibose 2mg/500mg/0.3mg Tablet on your body, your healthcare provider may recommend certain lab tests. These tests help in assessing how well your body is responding to the medication and managing your condition. The related lab tests for StayHappi Glimepiride+Metformin+Voglibose 2mg/500mg/0.3mg Tablet include:


1. Glucose - Fasting Blood: This test measures the level of glucose in your blood after fasting for a specific period. It helps in evaluating your blood sugar levels before taking any food or drink.


2. Glucose - Postprandial Blood: This test measures the level of glucose in your blood after consuming a meal. It helps in assessing how your body processes sugar after eating.


3. Glycosylated Hemoglobin: Also known as Hemoglobin A1c, this test provides an average of your blood sugar levels over the past 2-3 months. It helps in monitoring long-term glucose control in individuals with diabetes.


These lab tests are essential for monitoring your health while taking StayHappi Glimepiride+Metformin+Voglibose 2mg/500mg/0.3mg Tablet. Make sure to follow your healthcare provider's recommendations regarding the timing and frequency of these tests for effective management of your condition.


Additional Information

Habit FormingNo
Chemical Class-
Therapeutic ClassANTI DIABETIC
Action Class-

FAQs


Disclaimer

The information provided on this website is to the best of our abilities to ensure it is accurate, reliable, and reviewed by a team of professionals. It should not be used to diagnose, prevent, or cure any health problem. The information presented here is not intended to create a doctor-patient relationship or replace a registered medical practitioner's advice, diagnosis, or treatment. The absence or provision of any information or warning regarding any medicine should not be assumed as an implied or explicit assurance of safety or efficacy. We highly recommend consulting your registered medical practitioner for all queries or doubts related to your medical condition. Do not ignore professional medical advice or delay seeking it based on the content encountered on our website. We intend to support, not replace, the doctor-patient relationship.

55.56

Inclusive of all taxes

Content verified by

chevron-right

Dr. Archana Prabhakar

MBBS, M.Med (Family Medicine)

Last update on 01-Oct-2024